Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism

被引:74
作者
Brinton, RD
Proffitt, P
Tran, J
Luu, R
机构
[1] UNIV SO CALIF, PHARMACEUT SCI CTR, PROGRAM NEUROSCI, LOS ANGELES, CA 90033 USA
[2] UNIV SO CALIF, STAR PROGRAM, LOS ANGELES, CA 90033 USA
关键词
D O I
10.1006/exnr.1997.6619
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Regulation of both the outgrowth and the survival of neurons involved in cognitive function can have a significant impact on the function of neural networks involved in memory and other cognitive processes. Results of this investigation demonstrated that 17 beta-estradiol and the estrogenic steroids estrone, estriol, mestranol, and equilin induced significant increases in cortical nerve cell growth. Of the neurotrophic estrogenic steroids, equilin was most efficacious. We therefore conducted an extensive analysis of equilin-induced neurotrophism. Equilin induced highly significant increases in the growth of both the macro and micro features of cortical nerve cell morphology. The growth-promoting effects of equilin were present in both serum-containing and serum-free media, indicating that the growth-promoting effect of equilin is direct and not dependent upon factors present in serum. Analysis of the regional selectivity of equilin-induced neurotrophism in the cerebral cortex demonstrated that equilin significantly increased the growth of neurons from the frontal, temporal, and occipital regions, with neurons from the parietal region also influenced, though more modestly. We pursued the mechanism of equilin-induced neurotrophism and found that the growth-promoting effects of equilin were completely abolished in the presence of the glutamatergic NMDA receptor antagonist AP5. Equilin is a major component of Premarin, the leading prescribed pharmaceutical for estrogen replacement therapy for postmenopausal women in the United States. Results of this investigation have the potential of influencing the application and design of therapeutic agents for the prevention of cognitive decline in estrogen deficient women and for the prevention of Alzheimer's disease in postmenopausal women, a group that comprises a large sector of the population, the size of which will continue to grow in the coming decades. (C) 1997 Academic Press.
引用
收藏
页码:211 / 220
页数:10
相关论文
共 60 条
  • [1] ESTROGEN ACTION VIA THE CAMP SIGNALING PATHWAY - STIMULATION OF ADENYLATE-CYCLASE AND CAMP-REGULATED GENE-TRANSCRIPTION
    ARONICA, SM
    KRAUS, WL
    KATZENELLENBOGEN, BS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) : 8517 - 8521
  • [2] MEN AND WOMEN AGING DIFFERENTLY
    BARER, BM
    [J]. INTERNATIONAL JOURNAL OF AGING & HUMAN DEVELOPMENT, 1994, 38 (01) : 29 - 40
  • [3] HIGH, USUAL AND IMPAIRED FUNCTIONING IN COMMUNITY-DWELLING OLDER MEN AND WOMEN - FINDINGS FROM THE MACARTHUR FOUNDATION RESEARCH NETWORK ON SUCCESSFUL AGING
    BERKMAN, LF
    SEEMAN, TE
    ALBERT, M
    BLAZER, D
    KAHN, R
    MOHS, R
    FINCH, C
    SCHNEIDER, E
    COTMAN, C
    MCCLEARN, G
    NESSELROADE, J
    FEATHERMAN, D
    GARMEZY, N
    MCKHANN, G
    BRIM, G
    PRAGER, D
    ROWE, J
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (10) : 1129 - 1140
  • [4] METABOLISM OF [H-3] EQUILIN IN NORMAL AND MALIGNANT HUMAN ENDOMETRIUM AND IN ENDOMETRIAL ADENOCARCINOMA TRANSPLANTED INTO NUDE-MICE
    BHAVNANI, BR
    GERULATH, AH
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 38 (04) : 433 - 439
  • [5] BRECHER PI, 1968, P SOC EXP BIOL MED, V128, P470
  • [6] 17-BETA-ESTRADIOL INDUCTION OF FILOPODIAL GROWTH IN CULTURED HIPPOCAMPAL-NEURONS WITHIN MINUTES OF EXPOSURE
    BRINTON, RD
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 1993, 4 (01) : 36 - 46
  • [7] 17 beta-estradiol enhances the outgrowth and survival of neocortical neurons in culture
    Brinton, RD
    Tran, J
    Proffitt, P
    Montoya, M
    [J]. NEUROCHEMICAL RESEARCH, 1997, 22 (11) : 1339 - 1351
  • [8] BRINTON RD, 1994, J NEUROSCI, V14, P2763
  • [9] BRINTON RD, 1997, SOC NEUR ABSTR, V23
  • [10] BRINTON RD, 1996, SOC NEUR ABSTR, V22